Cough Drops From Several Brands Being Recalled, FDA Says
via HealthDayTHURSDAY, April 16, 2026 — Several common cough drop brands are being pulled from shelves after officials raised concerns about how they were made.
The U.S. Food and Drug Administration (FDA) said a China-based company, Xiamen Kang Zhongyuan Biotechnology Co., Ltd, issued a recall that includes 15 products.
The recall began March 20 and includes cough drops sold under five brands, Today.com reported:
The FDA said the action followed "certain observations" made during an inspection of the manufacturing facility on Aug. 15, 2025. The agency did not provide more details about the concerns.
So far, it’s unclear whether anyone has become sick from consuming the cough drops.
The recall has been labeled Class II, which the FDA says means the product "may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
Many of the affected items share the same lot number: 20241030, with an expiration date of Oct. 30, 2026, though some products have different lot codes and dates.
The cough drops come in a variety of flavors, including honey lemon, cherry and menthol, and were sold in bag sizes from 25 to 90 counts.
Because cough drops are considered drugs, the FDA says people should check product labels carefully before deciding what to do.
"In some instances, stopping your medicine may be more harmful to your health than continuing to take the recalled medicine," the agency said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-17 02:06
Read more
- Ionis Announces Zilganersen New Drug Application for Alexander Disease (AxD) Accepted by FDA for Priority Review
- ACC: Intensive LDL Cholesterol Targeting Beneficial for Patients With Atherosclerotic CVD
- Global Maternal Mortality Ratio Reported at 190.5 Deaths/100,000 Livebirths in 2023
- AAP Guidelines Address Parental Requests for Nonbeneficial Treatments
- AHA: Belly Fat Tied to Heart Failure Risk More Strongly Than Body Mass Index
- Disputing Link, Raw Dairy Farm Recalls Raw Cheese After Outbreak
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions